Literature DB >> 11411563

Inhibitory effects of anti-inflammatory drugs on interleukin-6 bioactivity.

B S Kang1, E Y Chung, Y P Yun, M K Lee, Y R Lee, K S Lee, K R Min, Y Kim.   

Abstract

Interleukin-6 (IL-6) is known as a proinflammatory cytokine involved in immune response, inflammation, and hematopoiesis. Inhibitory effects of anti-inflammatory drugs on IL-6 bioactivity using IL-6-dependent hybridoma have been evaluated. Three out of 16 nonsteroidal anti-inflammatory drugs (NSAIDs) showed IC50 values of less than 100 microM, which were in the order of oxyphenylbutazone hydrate (IC50=7.5 microM)>meclofenamic acid sodium salt (31.9 microM)>sulindac (74.9 microM). Steroidal anti-inflammatory drugs (SAIDs) exhibited significant inhibitory effects at 100 microM on the IL-6 bioactivity, and their inhibitory potencies were in the order of budesonide (IC50=2.2 microM)>hydrocortisone 21-hemisuccinate (6.7 microM), prednisolone (7.5 microM), betamethasone (10.9 microM)>dexamethasone (18.9 microM) and triamcinolone acetonide (24.1 microM). The results would provide an additional mechanism by which anti-inflammatory drugs display their anti-inflammatory and immunosuppressive effects at higher concentrations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11411563     DOI: 10.1248/bpb.24.701

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study.

Authors:  Sonali R Naikwade; Amrita N Bajaj; Prashant Gurav; Madhumanjiri M Gatne; Pritam Singh Soni
Journal:  AAPS PharmSciTech       Date:  2009-08-01       Impact factor: 3.246

Review 2.  The role of the immune system in neurofibromatosis type 1-associated nervous system tumors.

Authors:  Souvik Karmakar; Karlyne M Reilly
Journal:  CNS Oncol       Date:  2016-12-21

3.  Novel potential agents for ulcerative colitis by molecular topology: suppression of IL-6 production in Caco-2 and RAW 264.7 cell lines.

Authors:  María Galvez-Llompart; María Del Carmen Recio Iglesias; Jorge Gálvez; Ramón García-Domenech
Journal:  Mol Divers       Date:  2013-06-23       Impact factor: 2.943

4.  The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer.

Authors:  Kendall W Wannamaker; Sarah Kenny; Rishi Das; Aaron Mendlovitz; Jordan M Comstock; Edward R Chu; Sepehr Bahadorani; Nathan J Gresores; Kinley D Beck; Chelsey J Krambeer; Daniel S Kermany; Roberto Diaz-Rohena; Daniel P Nolan; Jeong-Hyeon Sohn; Michael A Singer
Journal:  Clin Ophthalmol       Date:  2019-06-27

Review 5.  The role of immunomodulators in treatment-resistant depression: case studies.

Authors:  Charles W Beckett; Maria Victoria Niklison-Chirou
Journal:  Cell Death Discov       Date:  2022-08-17

6.  Efficacy of single-dose intravitreal dexamethasone implantation for retinal vein occlusion patients with refractory macular edema: A systematic review and meta-analysis.

Authors:  Qiongzhen Yuan; Yunxia Gao; Yilin Liu; Hanyue Xu; Tong Wang; Ming Zhang
Journal:  Front Pharmacol       Date:  2022-09-28       Impact factor: 5.988

Review 7.  Intravitreal steroids for the treatment of retinal diseases.

Authors:  Valentina Sarao; Daniele Veritti; Francesco Boscia; Paolo Lanzetta
Journal:  ScientificWorldJournal       Date:  2014-01-08

8.  In vivo study of pro-inflammatory cytokine changes in serum and synovial fluid during treatment with celecoxib and etoricoxib and correlation with VAS pain change and synovial membrane penetration index in patients with inflammatory arthritis.

Authors:  Athina Theodoridou; Helen Gika; Eudoxia Diza; Alexandros Garyfallos; Loucas Settas
Journal:  Mediterr J Rheumatol       Date:  2017-03-28

9.  Magnoliae Cortex and maize modulate Porphyromonas gingivalis-induced inflammatory reactions.

Authors:  Jae-Yoon Kim; Kyoung-Hwa Kim; Eun-Hye Kwag; Yang Jo Seol; Yong Moo Lee; Young Ku; In-Chul Rhyu
Journal:  J Periodontal Implant Sci       Date:  2018-04-30       Impact factor: 2.614

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.